OR WAIT null SECS
Cambrex has announced the completion of its new facility at its Karlskoga site in Sweden that combines new laboratories for process and analytical development.
Cambrex has announced, in a June 4, 2019 press release, the completion of its new facility at its Karlskoga site in Sweden that combines new laboratories for process and analytical development.
The 600-m2 facility incorporates process technology, quality control, and analytical development laboratories, which will expand the company’s capacity and provide an area for R&D and production teams to work on scale up demonstration and tech transfer. Additionally, computer modeling will be used at the facility to optimize reactor set ups and plant conditions.
Additionally, the company reports that the lab includes high-pressure reaction vessels and crystallization equipment, which will be employed to optimize drug substance manufacturing and to expand the possible temperature range that can be used for reactions. The new quality control and analytical development labs enlarge the company’s capacity and capabilities for handling in-process and raw material analysis.
“This expansion and investments we have made at Karlskoga are part of an ongoing strategic program to ensure it has the flexibility, capacity, and capabilities to meet the evolving needs of the market and industry,” commented Bjarne Sandberg, managing director, Cambrex Karlskoga. “The new technical laboratory will act as a hub for the company’s engineers, operators, and chemists to ensure smooth scale up and handover of processes from development sites across our global network.”
This new facility, along with other recent growth seen at the site, will be supported by a new $6 million, 3000-m2 logistics center, which has already been completed and opened.